Results of TOR001: An open-label single patient study using targeted bacteriophage therapy for the treatment of chronic urinary tract infection.
Saved in:
| Title: | Results of TOR001: An open-label single patient study using targeted bacteriophage therapy for the treatment of chronic urinary tract infection. |
|---|---|
| Authors: | Cook JD; Unity Health Toronto, St. Joseph's Health Centre, Toronto, Ontario, Canada; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada., Hooey PB; Unity Health Toronto, St. Joseph's Health Centre, Toronto, Ontario, Canada., Salazar KC; Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX, USA; Tailored Antibacterials and Innovative Laboratories for Phage (Φ) Research (TAILΦR), Baylor College of Medicine, Houston, TX, USA., Clark JR; Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX, USA; Tailored Antibacterials and Innovative Laboratories for Phage (Φ) Research (TAILΦR), Baylor College of Medicine, Houston, TX, USA., Jain U; Unity Health Toronto, St. Joseph's Health Centre, Toronto, Ontario, Canada., Fernando C; Unity Health Toronto, St. Joseph's Health Centre, Toronto, Ontario, Canada., Harvey H; Department of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, Ontario, Canada., Cervantes A; Tailored Antibacterials and Innovative Laboratories for Phage (Φ) Research (TAILΦR), Baylor College of Medicine, Houston, TX, USA., Omagari S; Tailored Antibacterials and Innovative Laboratories for Phage (Φ) Research (TAILΦR), Baylor College of Medicine, Houston, TX, USA., Blankstein U; Department of Surgery, McMaster University, Hamilton, Ontario, Canada., Kropinski AM; Department of Pathobiology, University of Guelph, Ontario, Canada., Davidson AR; Department of Biochemistry, University of Toronto, Toronto, Ontario, Canada., Maxwell KL; Department of Biochemistry, University of Toronto, Toronto, Ontario, Canada., Burrows LL; Department of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, Ontario, Canada., Terwilliger AL; Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX, USA; Tailored Antibacterials and Innovative Laboratories for Phage (Φ) Research (TAILΦR), Baylor College of Medicine, Houston, TX, USA., Maresso AW; Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX, USA; Tailored Antibacterials and Innovative Laboratories for Phage (Φ) Research (TAILΦR), Baylor College of Medicine, Houston, TX, USA., German GJ; Unity Health Toronto, St. Joseph's Health Centre, Toronto, Ontario, Canada; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada; Unity Health Toronto, Li Ka Shing Knowledge Institute, Toronto, Ontario, Canada. Electronic address: Gregory.German@unityhealth.to. |
| Source: | International journal of antimicrobial agents [Int J Antimicrob Agents] 2025 Dec; Vol. 66 (6), pp. 107613. Date of Electronic Publication: 2025 Sep 08. |
| Publication Type: | Journal Article; Case Reports |
| Journal Info: | Publisher: Elsevier Science Publishers Country of Publication: Netherlands NLM ID: 9111860 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-7913 (Electronic) Linking ISSN: 09248579 NLM ISO Abbreviation: Int J Antimicrob Agents Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 40930191 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Results of TOR001: An open-label single patient study using targeted bacteriophage therapy for the treatment of chronic urinary tract infection. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Cook+JD%22">Cook JD</searchLink>; Unity Health Toronto, St. Joseph's Health Centre, Toronto, Ontario, Canada; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Hooey+PB%22">Hooey PB</searchLink>; Unity Health Toronto, St. Joseph's Health Centre, Toronto, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Salazar+KC%22">Salazar KC</searchLink>; Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX, USA; Tailored Antibacterials and Innovative Laboratories for Phage (Φ) Research (TAILΦR), Baylor College of Medicine, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Clark+JR%22">Clark JR</searchLink>; Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX, USA; Tailored Antibacterials and Innovative Laboratories for Phage (Φ) Research (TAILΦR), Baylor College of Medicine, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Jain+U%22">Jain U</searchLink>; Unity Health Toronto, St. Joseph's Health Centre, Toronto, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Fernando+C%22">Fernando C</searchLink>; Unity Health Toronto, St. Joseph's Health Centre, Toronto, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Harvey+H%22">Harvey H</searchLink>; Department of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Cervantes+A%22">Cervantes A</searchLink>; Tailored Antibacterials and Innovative Laboratories for Phage (Φ) Research (TAILΦR), Baylor College of Medicine, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Omagari+S%22">Omagari S</searchLink>; Tailored Antibacterials and Innovative Laboratories for Phage (Φ) Research (TAILΦR), Baylor College of Medicine, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Blankstein+U%22">Blankstein U</searchLink>; Department of Surgery, McMaster University, Hamilton, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Kropinski+AM%22">Kropinski AM</searchLink>; Department of Pathobiology, University of Guelph, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Davidson+AR%22">Davidson AR</searchLink>; Department of Biochemistry, University of Toronto, Toronto, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Maxwell+KL%22">Maxwell KL</searchLink>; Department of Biochemistry, University of Toronto, Toronto, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Burrows+LL%22">Burrows LL</searchLink>; Department of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Terwilliger+AL%22">Terwilliger AL</searchLink>; Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX, USA; Tailored Antibacterials and Innovative Laboratories for Phage (Φ) Research (TAILΦR), Baylor College of Medicine, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Maresso+AW%22">Maresso AW</searchLink>; Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX, USA; Tailored Antibacterials and Innovative Laboratories for Phage (Φ) Research (TAILΦR), Baylor College of Medicine, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22German+GJ%22">German GJ</searchLink>; Unity Health Toronto, St. Joseph's Health Centre, Toronto, Ontario, Canada; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada; Unity Health Toronto, Li Ka Shing Knowledge Institute, Toronto, Ontario, Canada. Electronic address: Gregory.German@unityhealth.to. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229111860%22">International journal of antimicrobial agents</searchLink> [Int J Antimicrob Agents] 2025 Dec; Vol. 66 (6), pp. 107613. <i>Date of Electronic Publication: </i>2025 Sep 08. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Case Reports – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+Science+Publishers%22">Elsevier Science Publishers </searchLink><i>Country of Publication: </i>Netherlands <i>NLM ID: </i>9111860 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1872-7913 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2209248579%22">09248579 </searchLink><i>NLM ISO Abbreviation: </i>Int J Antimicrob Agents <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40930191 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.ijantimicag.2025.107613 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 107613 Titles: – TitleFull: Results of TOR001: An open-label single patient study using targeted bacteriophage therapy for the treatment of chronic urinary tract infection. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Cook JD – PersonEntity: Name: NameFull: Hooey PB – PersonEntity: Name: NameFull: Salazar KC – PersonEntity: Name: NameFull: Clark JR – PersonEntity: Name: NameFull: Jain U – PersonEntity: Name: NameFull: Fernando C – PersonEntity: Name: NameFull: Harvey H – PersonEntity: Name: NameFull: Cervantes A – PersonEntity: Name: NameFull: Omagari S – PersonEntity: Name: NameFull: Blankstein U – PersonEntity: Name: NameFull: Kropinski AM – PersonEntity: Name: NameFull: Davidson AR – PersonEntity: Name: NameFull: Maxwell KL – PersonEntity: Name: NameFull: Burrows LL – PersonEntity: Name: NameFull: Terwilliger AL – PersonEntity: Name: NameFull: Maresso AW – PersonEntity: Name: NameFull: German GJ IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 12 Text: 2025 Dec Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 1872-7913 Numbering: – Type: volume Value: 66 – Type: issue Value: 6 Titles: – TitleFull: International journal of antimicrobial agents Type: main |
| ResultId | 1 |